Options. | Potential Actions. | Pros. | Cons. |
---|---|---|---|
Option 1: STAY / SEEK GROWTH |
|
|
|
Option 2: EXIT / SEEK LIQUIDITY |
|
|
|
JMI worked closely with senior team members in creating an entry strategy for European Markets.
A Middle Market Private Equity Firm.
Help monitor and improve portfolio companies’ performance by uncovering business insights within ERP (Enterprise Resource Planning) systems.
JMI’s solution comprised of the following approach:
A mid-market private equity fund wanted to invest in a US-based digital lending fintech company. Historically, the PE fund relied upon traditional, manual, and defensive methods of due diligence. The fund wanted to get deeper data-driven due diligence insights on the company’s products, market positioning, customer beliefs, and organizational culture. JMI's data analytics team was roped in to leverage the JMI data analytics platform to get actionable insights on four broad areas, which included:
JMI's proprietary models and data aggregation platform produced unique and powerful insights on business revenue and margin performances based on raw transaction-level data along with core business capabilities and market drivers such as production capacity, sales and distribution KPIs, cash flow, and potential trends in the competitive market, etc.
The JMI data analytics platform set up during diligence for investment evaluation was further extended to capture the company’s everyday business intelligence in order to retain the key insights and data sources that underpinned the deal thesis and value creation plan over the investment cycle.
The PE fund wanted to understand the customers’ perceptions of the various company products and their competitive positioning in the market. They specifically wanted to leverage the JMI data analytics platform to gain deeper insights into customer views for various products using social networking websites and understand product positioning relative to competitors.
JMI analyzed the cost of customer acquisition across different marketing channels of the fintech company and provided specific insights on
The client wanted to understand the potential contributions made by a customer to the company’s revenue across the years to estimate the customer lifetime value and gain deeper insights on optimal customer mix which could contribute to higher revenues in the future.
The PE fund was facing difficulties in getting insights into the organization’s culture. They wanted to get a clear picture on employee beliefs towards the target company and predict employee attrition rate. They further wanted to analyze the correlation between attrition rate vs employee experience, salary and education background, etc.
A large private equity fund whose 30% of portfolio comprised of e-commerce companies reached out to JMI to leverage its data analytics capabilities to identify actionable insights to increase gross sales for portfolio companies. Its specific briefs were to:
JMI’s solution comprised of the following three-phased approach:
Our client, one of the top 5 tech companies in the world, wanted to:
The client was a growth equity firm partnering with B2B software companies with a track record of 25+ strategic investments and 19 successful exits. The client wanted JMI to help them improve and streamline their deal-sourcing process. The criteria for identifying investment opportunities were as follows:
JMI was involved in the end-to-end process of deal sourcing including:
The outcomes achieved were the following:
Top 500 stocks from Emerging Market.
Portfolios are checked for historical outperformance to ensure that only consistently outperforming strategies are selected.
The team does in-depth quantitative research using statistical and fundamental parameters used for constituent screening and constantly manages portfolio risk using max drawdown, skew kurtosis and other volatility parameter.
The research team does individual stock picking after going through company reports and financials and decides on a host of qualitative and quantitative parameters to be considered while screening stocks for the respective strategy.
Following parameters are considered while assigning weights to stocks in this portfolio.
This portfolio has a real-time rebalance schedule. On a daily basis, the research team reviews this portfolio and realign the weights with the selected asset allocation strategy.
Ratios | Portfolio(Growth Strategy) | EM500 |
---|---|---|
PE Ratio | 25.38 | 21.93 |
PB Ratio | 2.38 | 2.45 |
Dividend Yield(%) | 0.86 | 1.82 |
Sharpe Ratio | 1.7 | 0.7 |
Drawdown | 18% | 40% |
Our client, a US-based hedge fund, wanted us to construct a portfolio comprising of biotechnology and pharmaceutical companies based in the US with a market cap in the range of USD 500 Mn to 2 Bn and in clinical-stage for COVID-19 Vaccine development.
Selected 100+ US-based Pharma and biotech Companies on key parameter.
Screened 30 companies based on key parameter like clinical stage, efficacy rate etc.
Conducted in-depth research on 30 companies and Selected 22 companies.
Back tested the portfolio with different weights to get optimal portfolio.
Tracked the Portfolio for a month.
A mid-size US multi-manager hedge fund wanted market research on an emerging market from a risk-reward scenario, market size & depth, liquidity & trading volumes, instruments, trading costs & infrastructure, and taxation & regulations.
JMI was involved in conducting initial market research covering all these aspects. Key findings of the project are listed:-
Our Client, a US-based hedge fund, wanted us to track the Technology, Media and Telecom sector and identify key economic factors that affect the revenue growth, operating cost, cost of capital etc. of portfolio companies and help them in updating the financial model with latest market updates.
In-depth Study on Sector to identify key metrics
Tracked the market-driven factors like liquidity, momentum and fund flow
Conducted Fundamental Research on Portfolio Company
Keep track on latest financials and key parameter for each company
Updated the model with key parameters on daily basis
Our client, a US-based hedge fund, wanted us to analyze the portfolio of stocks and identify the attributes that impact the performance of a portfolio.
JMI team Identified that c.13% of portfolio, 13 stocks have shown negative momentum during different time periods over a long time
Our client, a US-based hedge fund, wanted us to rank a large number of stocks and bonds targeted for long-term investments and review the relative performance of the assets to manage risks better.
Collected 2,000+ stocks from client which they wanted to analyze
Inherited fundamental data of each stock such as financials, shareholding pattern, daily return etc.
Applied JMI unique ML model to predict relative performance of each stock
Investigated through different ML models using FNN, RF and ANFIS
Ranked the stocks and analyzed their relative performance
Our client, a US-based hedge fund, wanted us to analyze a large number of stocks using alternative data.
Collected 500+ stocks from client which they wanted to analyze.
Extracted data from DTCC on trading volume in context of market activity.
Measured key parameter like volatility, risk and return trends with trade volume.
Compared Relative Performance trends of industry and sector for each stocks.
Analyzed the pattern and provide insights.
An investment fund developed a long short index trading strategy to generate additional alpha and reduce the draw down on overall fund performance. However, the actual realized results were significantly different from the back tested results leading to a sub-optimal performance of the fund.
Assessed the client’s quant strategy using in-house advanced quant platform and recorded following parameters:
Ran the Strategy on JMI’s proprietary quant platform, across multiple sections of in-sampled and out-sampled data and recorded strategy result dataset which showed varied performance across time frames.
On further statistical analysis across time periods, JMI identified that the back tested result dataset was influenced by high kurtosis (+9.5) and negative skew (-1.7), and this led to high deviation in actual and back tested performance of the long short strategy.
Optimized the long short strategy parameters by using multi-variate regression and statistical modelling.
Added new volatility-based indicator to the strategy which led to a significant improvement in overall strategy and actual results in line with the back tested results.
Long Only Fund wanted to develop quant models for real-time tracking of 1000+ listed stocks and optimize entry/exit of portfolio companies.
Building a long-short trading strategy that could work consistently in US stock markets and that can also be used as a hedge during volatile markets.
Created in 1957, the S&P 500 was the first US market cap-weighted stock market index. The index includes 500 leading companies and covers approximately 80% of available market capitalization. Today, it’s the basis of many listed and over-the-counter investment instruments.
The index is a capitalization-weighted index and the 10 largest companies in the index account for 28.1% of the market capitalization of the index.
Number of Constituents | 505 |
Constituent Market cap (USD Mn) | |
Mean Total Market Cap | 65,445 |
Largest Total Market cap | 2,243,557 |
Smallest Total Market Cap | 3,299 |
Median Total Market Cap | 25,919 |
Weight largest Constituent (%) 6.7 | 6.7 |
Weight Top 10 Constituents (%) | 28.1 |
IT sector companies constitute 27.8% of total market cap followed by consumer discretionary and financials companies. The 10 largest companies in the index, in order of weighting, are Apple Inc., Microsoft Corp., Amazon.com. Facebook Inc, Tesla Inc, Alphabet Inc (class A&C), Berkshire Hathaway, J&J, and JP Morgan Chase & Co.
Based on quantitative analysis of last 100 years of S&P 500 data, we found that S&P 500 trades
We believe that SPX may move towards a maximum of 4150 however risk-reward is not much in favor and hence eventfully may correct to 3000 levels in the next 2-3 years.
The index has highest annualized return of 18.6% in last 3 years with annualized risk of 11.0%.
Annualized Risk | Annualized Return | |
---|---|---|
3 Years | 18.6% | 11.0% |
5 Years | 15.0% | 15.5% |
10 Years | 13.5% | 12.8% |
Risk is defined as standard deviation calculated based on total returns using monthly values. All information as on January 30th, 2021.
The Nasdaq Composite Index measures all Nasdaq domestic and international-based common stocks listed on the Nasdaq Stock Market. The index is a large market cap-weighted index of more than 2,500 stocks, ADRs, and real estate investment trusts. The composition of the Nasdaq composite is heavily weighted towards companies in the Information Technology Sector.
As of December 30th, 2020, the industry weights of the Nasdaq composite Index’s individual securities are Technology at 48.1%, Consumer services at 19.5%, Health Care at 10.1%, Consumer Goods at 8%, Industrials at 5.9% and Financials at 5.4%.
Based on quantitative analysis of the last 35 years Nasdaq data, we found that Nasdaq trades
We believe that upside in Nasdaq is limited to maximum 10-15% from here while downside could be very high as it is moving into bubble zone not seen in the recent times.
The Dow Jones Industrial Average is a price-weighted measure of 30 US blue chip companies. The index covers all industries except transportation and utilities.
IT sector constitute 22% of its weight followed by 17.9% for healthcare and 16.4% for industrial sectors.
Based on quantitative analysis of last 30 years, we found that DJI trades
On comparing DJI index with other indexes, we believe that DJI can offer better risk-reward in the near future compared to NASDAQ, SPX and RUT.
DJIA has highest annualized return in last 5 years with annualized risk of 15.5%
Annualized Risk | Annualized Return | |
---|---|---|
3 Years | 18.8% | 6.3% |
5 Years | 15.5% | 14.6% |
10 Years | 13.6% | 11.6% |
Risk is defined as standard deviation calculated based on total returns using monthly values. All information as on January 30th, 2021
The Russell 2000 Index measures the performance of the small-cap segment of the US equity universe. The Russell 2000 Index is a subset of the Russell 3000 Index representing approximately 10% of the total market capitalization of that index. As of January 31st , 2021, the weighted average market capitalization for a company in the index is around $3.8 billion, the median market cap is $922 million. The market cap of the largest company in the index is $28.65 billion.
As of December 31st, 2020, the sector with the largest weight in the index is Health Care sector which accounts for 21.1% followed by Industrials and Financials, each account for 15.3%. The smallest contribution is by the energy sector.
Based on quantitative analysis of the last 33 years data, we found that RUT trades
We believe that there is no major upside left in RUT and risk-reward is not at all in the favor of any long trades in RUT. We expect RUT to fall to 1500 levels in the next 2-3 years.
Russell 2000 has highest annualized return of 16.5% in last 5 years with annualized risk of c.21%.
Annualized Risk | Annualized Return | |
---|---|---|
3 Years | 25.3% | 11.1% |
5 Years | 20.9% | 16.5% |
10 Years | 18.8% | 11.7% |
All information as on January 31st, 2021
A US-based Asset Manager with 20+ years of experience and AUM of over USD2.5bn in the global capital markets reached out to JMI for equity research and valuation model support across multiple sectors.
A Portfolio Manager at a US$5bn event driven fund needed help evaluating a potential special situations investment opportunity. He believed that a leading player in the global manufacturing space was being undervalued (by potentially as much as 50%), as a stand-alone entity when compared to the sum of its parts. JMI was engaged to perform a viability study of the client hypothesis, identify mile markers likely to catalyze a valuation re-rating and develop qualitative and quantitative metrics as well as sensitivities around up/down side scenarios.
A US-based IB firm requested for a detailed research report on a public listed US-based telecom company to get an actionable investment ideas followed by
Our Client, US headquartered mid - market IB firm was advising a digital lending start-up on its acquisition by a large conglomerate.
Our Client, US-based IB firm, received a mandate to advise a buy side acquisition of a US-based Payments Company, that was looking for Cross-selling synergies and opportunity to increase its end-customer base.
An established family office serving a multi-generational family with assets of $150M and investments across different geographies was thinly staffed and needed a flexible range of services to facilitate their accounting and reporting process.
The client seeks JMI's close collaboration to receive comprehensive support in optimizing their portfolio's performance and making informed investment decisions. By leveraging JMI's expertise, the client aims to obtain valuable recommendations and guidance, enabling them to strategically align their investment choices with their specific goals, risk tolerance, and long-term objectives.
Our client, ABC Investments holds a portfolio of CLOs. The client wanted us to help assess the valuation of its CLO portfolio to understand its current worth and make informed investment decisions.
Our Client, a US-headquartered VC firm was advising a K-12 EdTech start-up on its acquisition by a large conglomerate.
Reduce initial population homogeneity.
Excessive initial homogeneity in patient profiles leads to a delay in finding ideal patient profiles to target for recruitment. This is typically referred to as the “Explore vs Exploit” problem in machine learning literature. This can be tackled by training a model to predict how much someone would diversify a clinical trials test group based on the currently enrolled population. This would allow additional effort towards finding people that would increase the initial patient profile diversity, reducing the effort to find patients, guide targeting of new patient profiles, and ideally increase the chance for the clinical trial to pass (given that the drug/therapy is successful). This is particularly relevant if the currently enrolled patients are not doing well in the therapy.
EHR data and data generated from the trial.
Predictive Enrichment
Massive amounts of monitoring data can easily overwhelm medical professionals and lead to an increased time cost or a higher error rate. Machine learning can be used to highlight areas of interest in the monitoring data to show issues that medical professionals might miss. Depending on the scale, this can be extended to directly aid the medical professional in the analysis of the generated data.
Data generated from at-home monitoring and reporting systems.
Prognostic Enrichment.
Predict the doctor’s estimate of the patient’s condition with empirical data. The purpose is to detect and curb possible biases in trial methodology or in medical professionals.
EHR data and data generated from the trial.
Create a system that can use an image of the sponsor-created checklist and automatically fill out the database and web portal.
Prognostic Enrichment.
Proxy for expensive biomarkers.
Data.
Real-World Evidence.
Drugs make it to market but are recalled due to showing Drug Induced Liver Injury (DILI). Forecasting DILI has been attempted before; however, a large body of real-world data is underutilized. Real-world data was used as a method of prediction.
Identifying patient subtypes
Increase success rate of doctors observing key events and reducing associated costs.
Complex sensor data (EEGs).
The ability to observe patients having seizures is very valuable in a hospital due to under-minute duration (often 5-sec or less) and diagnostic necessities from higher-order staff. Value add is to predict ahead of time to allow observation for diagnostics. Long-term situations are directly diagnosed since doctors are empirically fallible to a high degree.
Developed a custom model predict seizures in advance using live EEG data to alert medical professionals in advance of the event.
Reducing Heterogeneity.
Identifying patient subtypes.
Recruitment.
Patient screening.
Data.
Direct use of biomarkers.
Successful diagnosis and efficacious treatment of lupus take months and often even years due to lack of early, cost-effective, and effective diagnostics tests. After diagnostic tests are accomplished, patients must try many different medications until an effective regimen is found. This is further complicated by the varying presentations of lupus - flare, inactivity, and remission, as well as persistent chronic presentations.
Developed a custom model to diagnose lupus as well as aid in identifying patient subtypes and stages by leveraging Machine Learning and Deep Learning techniques in collaboration with the use of IES* diagnostic testing technology.
A global pharmaceutical company with OTC business through global pharmacy chains.
Improvement in Customer Journey Design, Customer Affinity Prediction, and Next best actions and field suggestions.
Instead of single-tactic execution, the scope of the campaign now uses a coherent sequence of tactics which includes advanced machine learning techniques to find marketing tactics that have worked well (Schematic on next Slide). The algorithm develops the most optimal sequence from historical data and self-learns to continually improve sequence generation as more data becomes available.
The personalization of tactics improves customer engagement and can be achieved by affinity prediction through the analysis of healthcare professionals’ interaction data across different types of channels (email, websites, mobile alerts) and content (product efficacy, safety, tolerability, patient services). Aligning the promotional content and channel to healthcare professionals’ affinities can garner up to three times the engagement.
The next best action programs are based on near-real-time customer interaction data sets and multivariate computations while leveraging customer affinities and optimal tactic sequences, making engagement initiatives significantly more dynamic. Call-to-action recommendations to sales reps to enhance the quality of patient interactions and feedback collection to enable learning and optimization.
A global pharmaceutical company with OTC business through global pharmacy chains.
Improvement in Patient Adherence, Patient Switch Propensity, KOL Mapping and Referral Patterns.
Algorithms that can learn relationships between diagnoses, treatments, procedures, and prescriptions can drive significant competitive advantage across therapeutic areas. It can help brands mobilize field resources throughout patient journeys, and proactively trigger predictive actions, such as a new patient diagnosis, the patient switch propensity to competitive brands and patient discontinuations.
Disease Diagnosis
DIAGNOSIS
Patient receives prescription (own or competing brand).
Physician refers patient to an infusion centre.
THERAPY SELECTION OR REFERRAL
Patient returns for treatment
ADHERENCE
Physician continues to monitor patient
MONITORING
The mapping of leading healthcare professional influencers and their networks—leveraging data from social media and online communities— can bring immense value, including leading adoption targets for new product launches and identification of key opinion leaders for speaker programs. Search algorithms help to identify physician communities, referral patterns, and influence networks of physicians.
A NASDAQ - listed biopharmaceutical firm treating rare and life-threatening diseases.
Multiple low to complex challenges in the Sales & Marketing function, ranging from automation of Physician Notes to patient discontinuation.
JMI introduced Commercial Analytics Lab (CAL), an in-house CoE for Sales & Marketing function :
Develop a custom model to effectively diagnose lupus with higher accuracy than currently available by leveraging Machine Learning and Deep Learning techniques in collaboration with the use of IES* diagnostic testing technology.
At this point in time, the industry standards for modeling do not provide the outcomes needed on successful diagnosis and efficacious treatment of lupus , let alone guide treatment research.
A US-based automobile insurance company experienced higher claims settlement times and wanted to use data analytics to further streamline claim settlement times.
A US-based Insurance Company wanted to leverage Social Network Analysis tool (SNA) to manage risk and detect fraud.
A large Insurance Company wanted to
A US-based Insurance Company wanted to get insight on
Insurance provider selling innovative personal, auto and commercial insurance products.
Reduce operational cost and maximize time-to-value for claim settlement and improve claim verification process across the value chain.
JMI’s solution comprised of the following three-phased approach:
The client was very pleased with the final product, particularly around the much lower cost and ease of administration. Additional iterations of the platform are already being seamlessly deployed, with the underlying infrastructure able to handle any amount of additional data or load from end users.
We were able to collect data, perform quality review and deliver 2500 companies within five months of the original request.
The Corporate ESG assessment report provided a complete review of the companies, and in a matter of 6 months, the client has been able to launch their custom ESG Assessment report.
Our client, a leading US-based PE firm specializing in the real estate sector, wanted us to pull data from multiple sources and integrate it to build dashboards and derive meaningful business-driven insights for their portfolio investments spread across ten states in the United States of America. Traditionally, the PE firm relied upon labor-intensive research methods by maintaining as many Excel files as the number of sources and portfolio sites. The JMI Analytics Team was roped in to simplify the entire workflow process, delivering value and offering solutions in three broad areas:
US based Real Estate fund asked JMI to carry out the due diligence process for a potential investment in Mobile home park in Florida.
The JMI team analyzed the property from various parameters which included:
Our client, a leading US-based PE firm specialized in the real estate sector wanted us to pull-in data from multiple sources and integrate them to build dashboards and derive meaningful business-driven insights for their portfolio investments spread across ten states in United States of America.
A United-States based Real Estate Fund wanted to raise money for acquisition of one property.
Our Client, a leading US-based Real Estate Fund wanted to create financial model for one of its portfolio properties.
Our Client asked to work closely with a senior team member of the client in creating an entry strategy for European Market.
The client was a growth equity firm partnering with B2B software companies with a track record of 25+ strategic investments and 19 successful exits. The client wanted JMI to help them improve and streamline their deal-sourcing process. The criteria for identifying investment opportunities were as follows:
JMI was engaged in the end-to-end process of deal sourcing including:
Our client is a US-based VC firm that wanted to invest in a digital lending company. The client requested a detailed research report to get an actionable investment idea followed by:
JMI was engaged in the end-to-end process of deal sourcing including:
Our Client, a US-headquartered VC firm was advising a K-12 EdTech start-up on its acquisition by a large conglomerate.
JMI was engaged in the end-to-end process of deal sourcing including: